EU drug regulator begins real-time review of Sinovac's Covid-19 vaccine
Data on the vaccine, Covid-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed-up potential approvals, the European Medicines Agency said
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Europe's medicines regulator said on Tuesday it has started a real-time review of Sinovac's Covid-19 vaccine, based on preliminary results from animal and human trials that suggested the vaccine produces an immune response against the coronavirus.
Data on the vaccine, Covid-19 Vaccine (Vero Cell) Inactivated, will be assessed as they are made available to help speed-up potential approvals, the European Medicines Agency said.
Keep updated, follow The Business Standard's Google news channel
